The size of the pharmaceutical isolator market in the European region is expected to grow at a CAGR of 4.39% from 2023 to 2028 and be worth USD 3,919.42 million by 2028 and USD 3,161.43 million in 2023.
The growing demand for pharmaceutical isolators from the pharmaceutical and biotechnology industries and low operating costs are the significant factors influencing the market's growth. The immense guarantee of sterility of pharmaceutical isolators translates into the expansion of the size of the market. Preparations of active pharmaceutical ingredients or APIs with high potency and contain substances such as hormones, antibiotics, etc., prone to contamination. The pharmaceutical isolator technology provides access to a safe environment that ensures operator safety and maintains the quality standard of the finished product. In 2019, the annual turnover of UK pharmaceutical wholesalers was over £ 52 billion. The UK pharmaceutical market is among the top 10 national markets globally, accounting for around 2.6% of the global pharmaceutical sector. In 2019, Germany's pharmaceutical industry sales increased by 5.8%, reaching 47 billion euros. Currently, more than 500 pharmaceutical companies are established in Germany. These numbers depict the intense growing demand for pharmaceutical products, which increases toxic and hazardous materials. The pharmaceutical isolators limit contamination and provide a bio-decontamination environment where only the drug and material of manufacture come into contact with the entire processing system. The increasing use of aseptic methods will improve the growth rate of the pharmaceutical isolators market in Europe.
The introduction of robotic technology in the studied market improves the quality level and product use. In the manufacturing process of pharmaceutical industries, repetition of the production procedure is mandatory because it increases the reproducibility of quality, which can only be achieved with the advent of robotic technology. Therefore, the research and technology industry is constantly working on robotic technology so that better product ideas emerge in the future. The automated bio-decontamination process allows for repeated high levels of disinfectant in the pharmaceutical isolator. With an increase in imports of pharmaceuticals (365 billion USD) and exports (525 billion USD) in 2021, the pharmaceutical manufacturing industry is growing with demand. The level of sterility assurance (SAL), i.e., with hydrogen peroxide, is much higher than that of disinfected clean rooms, which is expected to drive the growth of the European pharmaceutical isolator market.
However, the presence of restricted access barrier systems in the healthcare industry for aseptic processes and the high implementation cost associated with pharmaceutical isolators act as market restraints that are anticipated to hamper the market's growth. Furthermore, the high operating and isolator costs and strict government regulations and policies to maintain drug safety will challenge the European pharmaceutical isolator market even more.
This research report on the European pharmaceutical isolator market has been segmented and sub-segmented into the following categories.
By Product Type:
By Configuration:
By Application:
By End-user:
By Country:
The regional market in Germany dominated the European market in 2022 and is estimated to continue to influence throughout the forecast period. Germany is expected to have a compound annual growth rate of 5.9%, while the United Kingdom market could have a compound annual growth rate of 6.3% over the forecasted period. The regional market in the United Kingdom is expected to grow positively due to factors such as the faster acceptance of advanced health products, increased investment in the pharmaceutical isolator market by key players, and advancement in manufacturing processes. In addition, the guidelines established by the United States Food and Drug Administration and the European Medicines Agency for sterilization procedures will play an essential role in the adoption of pharmaceutical isolators.
Other regional markets in France, Sweden, and Spain will grow to meet the unmet needs of the growing pharmaceutical industry in the years to come.
KEY MARKET PLAYERS:
Companies playing a leading role in the European pharmaceutical isolator market profiled in this report are SKAN, Getinge, Extract Technology (Walker), Comecer, Hosokawa Micron, ZHEJIANG TAILIN Bioengineering, Fedegari Autoclavi, Telstar, Syntegon, Bioquell, Shanghai Tofflon Science and Technology, Wenzhou Weike Biological Laboratory Equipment, IsoTech Design and Flow Sciences, Inc. (FSI).
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region